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The Specific Vulnerabilities
of Cancer Cells to the Cold
Atmospheric Plasma-Stimulated
Solutions
Dayun Yan1, Haitao Cui1, Wei Zhu1, Niki Nourmohammadi2, Julian Milberg3, Lijie G. Zhang1,
Jonathan H. Sherman4 & Michael Keidar1
Cold atmospheric plasma (CAP), a novel promising anti-cancer modality, has shown its selective anticancer capacity on dozens of cancer cell lines in vitro and on subcutaneous xenograft tumors in mice.
Over the past five years, the CAP-stimulated solutions (PSS) have also shown their selective anticancer effect over different cancers in vitro and in vivo. The solutions used to make PSS include several
bio-adaptable solutions, mainly cell culture medium and simple buffered solutions. Both the CAPstimulated medium (PSM) and the CAP-stimulated buffered solution (PSB) are able to significantly kill
cancer cells in vitro. In this study, we systematically compared the anti-cancer effect of PSM and PSB
over pancreatic adenocarcinoma cells and glioblastoma cells. We demonstrated that pancreatic cancer
cells and glioblastoma cells were specifically vulnerable to PSM and PSB, respectively. The specific
response such as the rise of intracellular reactive oxygen species of two cancer cell lines to the H2O2containing environments might result in the specific vulnerabilities to PSM and PSB. In addition, we
demonstrated a basic guideline that the toxicity of PSS on cancer cells could be significantly modulated
through controlling the dilutability of solution.
Cold atmospheric plasma (CAP) is a near room temperature ionized gas composed of charged particles, neutral
particles, and electrons1. Among these particles, the oxygen-based reactive species and the nitrogen-based reactive species may mainly contribute to the interaction between CAP and cells2–6. Over the past decade, CAP has
shown its remarkably selective anti-cancer capacity in vitro5–9. Moreover, CAP is able to significantly reduce the
size of subcutaneous xenograft tumors in mice models by a direct treatment just above the skin10–15. The direct
CAP treatments rely upon a CAP generating device during the treatment. Over the past five years, the indirect
CAP treatment became a new topic in plasma medicine. The indirect CAP treatment uses the CAP-treated biologically adaptable solutions (PSS) to affect the growth of cancer cells in vitro13, 16–30 or in vivo by injecting PSS into
the tumor tissues17, 30. PSS can be stored over a long time length at −80 °C20, 26 by optimizing the composition of
the solution24. Thus, PSS can be used without the dependence on the CAP generating device. In addition, cancer
cells were actually covered by a thin layer of medium or other simple buffered solutions during the direct CAP
treatment15, 31, 32. This thin layer of solution facilitates the transition of the CAP-originated reactive species in the
gas phase to be the dissolved species in the aqueous solutions5, 33. Thus, the study of PSS will also facilitate the
understanding on the direct CAP treatment.
Compared with the abundant studies on the direct CAP treatment, the understanding of the anti-cancer effect
of PSS is lacking. To date, only four biologically adaptable solutions have been used as PSS. Most studies used cell
culture medium to make PSS13, 16–30, 34–36. Few studies used simple buffered solutions such as phosphate buffered
solution (PBS)24, 36, 37 and Lactated Ringer’s solution30 to make PSS. To investigate the anti-cancer capacity of PSS
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Figure 1. Typical strategies of using PSS to affect the growth of cancer cells in vitro. The differences between
these strategies are just due to one fact that a simple buffered solution such as PBS and Lactated Ringer’s
solution cannot be used to culture cells over a relative long time length. Step ①: Making PSM/PSB by treating
the solutions with CAP. Step ②: Using PSM/PSB to affect the growth of cancer cells. Step ③: Culturing the cancer
cells in PSM or medium overnights until the final cell viability assay. PSM: CAP-stimulated medium. PSB: CAPstimulated simple buffered solution.

in vitro, at least three research strategies have been proposed (Fig. 1). In this study, the CAP-stimulated medium
and the CAP-stimulated simple buffered solution is designated as PSM and PSB, respectively. Considering the
fact that medium as the control is suitable for cell culture over a long time, PSM can be used to culture cancer cells
overnight13, 16–30, 34–36. Whereas, the simple buffered solutions without the necessary nutrients can be just used
to affect the cancer cells for a relative short time such as several hours. At least two research strategies have been
developed for PSB. One is directly using PSB to affect cancer cells for a short time length such as several hours30.
After that, PSB is replaced by the untreated medium. The cancer cells will be cultured in the new medium overnight until the final cell viability assay or other analysis is performed. Another strategy is using the mixture of PSB
and the untreated medium to culture cells overnight. In this case, despite the medium will be diluted by PSB, its
nutrient will still sustain the growth of cancer cells overnight24.
The understanding of the anti-cancer mechanism of PSM has been extensively investigated. The CAP-original
reactive species such as H2O218, 20–22, 24, 26, 34, NO2− 27, 37, as well as NO3− 27, 37 have been regarded as the key
anti-cancer species in PSM. Catalase or other simple chemicals such as cysteine and methionine can effectively
eliminate the anti-cancer capacity of PSM through consuming H2O220, 21, 38. Thus, H2O2 may be a key anti-cancer
species formed in PSM. H2O2 can cause DNA damage on cancer cells, which is mediated by hydroxyl radicals generated from H2O2 by the Fenton reaction39. H2O2 is also an efficient inductor for the apoptosis in cancer cells39, 40.
H2O2-generating drugs can effectively kill cancer cells by the increase of cellular levels of H2O239. Experimental
evidences demonstrate that cancer cells are more susceptible to H2O2 with specific concentration than normal
cells39, 41, 42. Moreover, increasing the concentration of reactive species in PSM by chemical methods20, 24 or physical methods21 is an effective strategy to optimize the anti-cancer capacity of PSM.
Whereas, the understanding on the anti-cancer mechanism of PSB is just limited to few refs 24, 30, 36 and 37.
The anti-cancer capacity of PSB is highly affected by the research strategies chosen by authors. Compared with
PSM, the killing effect of PSB is always weaker. As early as in 2011, Sameer Kalghatgi, et al. first found that
noticeable double strand DNA breaks just occurred in the CAP treatment on medium rather than on PBS43. Very
recently, Hiromasa Tanaka, et al. found that the CAP-treated water could not cause the noticeable killing effect
on glioblastoma cells (U251SP)30. Corresponding noticeable rise of intracellular reactive oxygen species (ROS)
just occurred in the cells cultured in PSM rather than in PSB30. In fact, the H2O2 generation in PSM and PSB are
similar in these cases30. These contradictions indicate that just the reactive species in PSB may not necessarily
result in a noticeable damage on cancer cells. However, it is widely observed that the reactive species in PSM
would definitely cause noticeable cancer cells death13, 16–30, 34–36. In addition, we have found that using the PSB/
untreated DMEM mixture could also achieve a significant anti-cancer effect over glioblastoma cells (U87MG),
pancreatic adenocarcinoma cells (PA-TU-8988T), as well as breast adenocarcinoma cells (MDA-MB-231). In
short, the anti-cancer species may be toxic to cancer cells just in PSM or PSB/medium mixture rather than in PSB.
The unique characteristics differentiating PSM and PSB, and their subsequent interaction on cancer cells have yet
to be elucidated.
In this study, we systematically compared the anti-cancer effect of PSM and PSB on two cancer cell lines,
U87MG and PA-TU-8988T. We identified that the effect on cancer cells is cell-dependent and dose-dependent.
Both PSM and PSB could inhibit the growth of cancer cell lines when the right experimental conditions were set.
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x
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U87MG cells and PA-TU-8998T cells were highly vulnerable to PSB and PSM, respectively. The measurement of
intracellular ROS of two cell lines in PSM and PSB first revealed that the different cellular responses in medium
and in PBS might cause the different vulnerabilities of cells to PSM and PSB.

Methods

CAP device. The CAP jet device was designed and assembled in our lab and has been used in a series of
studies about the anti-cancer capacity of the CAP treatment in vitro19, 21, 25, 44, 45 and in vivo10. It used helium as
the carrying gas. The CAP jet was formed by the discharge between a ring grounded cathode and a central anode
and was flowed out (4.7 L/min) the quartz tube with a diameter of 4.5 mm. The input voltage of DC power was
11.5 V. The output voltage was 3.16 kV. The plasma discharge was driven by an AC high voltage with a frequency
of 30 kHz.
Cells culture. Human glioblastoma (U87MG) cells and human pancreas adenocarcinoma (PA-TU-8988T)
cells were provided by Dr. Murad’s lab at the George Washington University. Human breast adenocarcinoma cells
(MDA-MB-231) were provided by Dr. Zhang’s lab at the George Washington University, and were cultured in
the same protocol as previous studies46, 47. The Dulbecco’s modified Eagle’s medium (DMEM, with L-glutamine,
11965–118) was purchased from Life Technologies. DMEM was mixed with 1% (v/v) antibiotic (penicillin and
streptomycin) solution (Life Technologies). The media used in cell culture were composed of DMEM supplemented with 10% (v/v) fetal bovine serum (ThermoFisher Scientific). All wells on the margins of a 96-wells plate
(61406–081, Corning) were not used in this study. Only 6 wells in a single column on a 96-wells plate were used
to seed cells. 100 μL of the cells-harvesting solution (6 × 104 cells/mL) were seeded in each well. Cancer cells were
grown for 1 day under the standard culture condition (a humidified, 37 °C, 5% CO2 environment). The media that
have been used to culture cells overnight were removed before using PSM or PSB to treat cancer cells.
Extracellular H2O2 assay. The H2O2 concentration in sample solutions was measured by using Fluorimetric
Hydrogen Peroxide Assay Kit (Sigma-Aldrich) following the protocols provided by manufacturer. Finally, 50 μL
of H2O2 probe solution was mixed with 50 μL of sample in the black 96-wells plate. After 30 min of storage at the
room temperature without the ambient light, the fluorescence was measured by a H1 microplate reader (Hybrid
Technology) at 540/590 nm. The final fluorescent strength of the experimental group was obtained by deducting
the fluorescence of the control group from the fluorescence of the experimental group. The H2O2 concentration
in the samples were calculated based on the standard curve. In each experiment, the sample number was 3. The
average of 3 samples was set as one result.
Making (N-acetyl-L-cysteine) NAC containing DMEM (NAC-DMEM) and pre-treating cancer cells. 6 mM and 10 mM NAC-DMEM were made by dissolving NAC powder (A7250, Sigma-Aldrich)

in DMEM. As an intracellular ROS scavenger, NAC will penetrate the cytoplasmic membrane and resist the
redox balance change due to the rise of intracellular ROS13, 17, 48. To pre-treat cancer cells with NAC-DMEM, the
medium which has been used to culture cancer cells overnight were removed first. Then, 100 μL of NAC-DMEM
were used to culture the cancer cells in each well of a 96-wells plate. After 3 hr, the NAC-DMEM were removed.
These cancer cells were ready for the further treatment.

Making PSM/PSB, H2O2-containing DMEM/PBS (H2O2-DMEM/PBS), NO2−-containing DMEM
(NO2−-DMEM) and treating cancer cells. In this study, Lonza BioWhittaker Dulbecco’s PBS did not

contain calcium and magnesium (BW17512F12, Fisher Scientific). To make PSM/PSB, 1 mL of DMEM in a well
of a 12-wells plate (61406–165, Corning) was treated by CAP. The gap between the bottom of 12-wells plate and
the CAP source was 3 cm. To make H2O2-DMEM/PBS, 9.8 M H2O2 standard solution (216763, Sigma-Aldrich)
were added in DMEM or PBS with a designed concentration. Similarly, to make NO2−-DMEM, 0.1 M nitrite ion
standard solution (72586, Sigma-Aldrich) was added in DMEM with a designed concentration. To affect the
growth of cancer cells, 100 μL of the prepared solutions including PSM/PSB, H2O2-DMEM/PBS, NO2−-DMEM
was transferred to affect cancer cells grown on a 96-wells plate immediately after the preparation. For the control
group, cancer cells were just cultured in the untreated DMEM or in the untreated PBS. In each experiment, the
sample number was 6. For the experiment using the PBS-based solutions, cancer cells were just cultured in the
CAP-stimulated PBS for 3 hr. The new DMEM replaced the CAP-stimulated PBS after that and further sustained
the culture for 1 day. For the experiment using DMEM, cancer cells were cultured for 1 day after the treatment.
These sextuplicate experiments were independently repeated for at least twice.

Measuring the H2O2 consumption speed by cancer cells. The protocols for different cancer cell lines
were identical. Here, we used U87MG cells as an example. First, 100 μL of cells harvesting solution with a confluence of 6 × 104 cells/mL were seeded in a well on a 96-wells plate. In each experiment, 3 wells on 96-wells plate
were seeded with cells as 3 samples. Cells were cultured in the incubator for 7 hr under the standard conditions.
Then, 1 mL of DMEM or PBS in a well on a 12-wells plate was treated by CAP for 1 min. After that, 100 μL of PSM
or PSB was transferred to culture cells grown on a 96-wells plate. The medium which has been used to culture cells
was removed before this step. Since then, 50 μL of medium which has been used to culture cells was transferred
to a well on a black clear bottom 96-wells plate (29444–008, Corning) in triplicate every hour until the third hour.
Ultimately, the residual H2O2 concentration in PSM or PSB was measured using fluorimetric assay illustrated
above.
Making the diluted PSM and affecting cancer cells.

We prepared a series of diluted DMEM by gradually increasing the dilution fraction of PBS in DMEM from 0% to be 90%. The corresponding dilutability of
DMEM gradually decreased from 0% to be 90%. Because cancer cells needed to be cultured overnight, we have
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not performed the experiment with a 100% of dilutability. Then, 1 mL of DMEM with different dilutabilities in
a well of 12-wells plate (61406–165, Corning) was treated by CAP. The gap between the bottom of 12-wells plate
and the CAP source was 3 cm. To affect the growth of cancer cells, 150 μL of PSM with different dilutabilities was
transferred to affect cancer cells grown on a 96-wells plate immediately. In control groups, cancer cells were just
cultured in the untreated DMEM with different dilutabilities. In each experiment, the sample number was 6.
Cancer cells were cultured for 1 day before the cell viability assay. All experiments were independently repeated
for at least 3 times in sextuplicate.

Cell viability assay. The cell viability was measured by using MTT (3-(4,5-Dimethyl-2-thiazol)2,5-Diphenyl-2H-tetrazolium Bromide) assay following the standard protocols provided by manufacturer
(M2128, Sigma-Aldrich). The 96-wells plate was read by a H1 microplate reader (Hybrid Technology) at an
absorbance of 570 nm. To facilitate the formation of final violet solution, the 96-wells plates were shook for 30 s
before reading. To facilitate the data analysis, the measured absorbance at 570 nm was processed to be a relative
cell viability by the division of absorbance between the experimental group and the control group. In each experiment, the cell viability was equal to the mean of 6 samples from 6 wells.
Measuring intracellular ROS.

The cell permeant 2,7-dichlorodihydrofluorescein diacetate
(CM-H2DCFDA), a general oxidative stress indicator (ThermoFisher Scientific) has been widely used as the
intracellular ROS probes in plasma medicine, though the determination of intracellular ROS by these probes may
be influenced by the level of free cytochrome c in cells49. 500 mL of 1× buffer (113851, Abcam) were added into
the tube containing 50 μg of molecular probes CM-H2DCFD to prepare the 1× stock solution. 1× stock solution
was further diluted to be 0.03125× stock solution. Prior to the measurement, 100 μL of 25 × 104 cells/mL cells
were seeded in the well on a black clear bottom 96-wells plate (29444–008, Corning) and were cultured for 1
day. For each case, the samples in experimental group and control group were all 3. The controls groups and the
experimental groups were the measurements performed on cancer cells just cultured in the untreated DMEM/
PBS and in the H2O2-DMEM/PBS, respectively. The 10 min- and 20 min-equivalent H2O2-DMEM/PBS were prepared by adding 30 wt % (9.8 M) H2O2 solution (216763, Sigma-Aldrich) in DMEM/PBS. The concentration of
10 min- and 20 min-equivalent H2O2-DMEM/PBS were 367.5 μM and 735 μM, respectively. The intracellular ROS
measurement of PA-TU-8988T cells and U87MG cells began 3 hr and 50 min after the H2O2 treatment on cells,
respectively. Cells were washed by 100 μL of 1× buffer. Then, cells were cultured in 100 μL of 0.03125× stock
solution for 50 min. Subsequently, 100 μL of PBS was used to replace the stock solution in each well. Finally, the
fluorescence was measured by a H1 microplate reader (Hybrid Technology) at 485/535 nm. For the data processing, the measured fluorescence of the control groups and the experimental groups were first subtracted by the
fluorescence of background (just PBS). The fluorescence of the experimental group was modified by subtracting the fluorescence of the control group. Ultimately, the modified fluorescence of the experimental groups was
modified to be a relative intracellular ROS based on the following formula. Relative intracellular ROS = Modified
experimental groups/Modified control group.

Data availability statement. All data generated or analysed during this study are included in this published article (and its Supplementary Information files).
Experiments and results. PBS cannot be used to culture cancer cells for a relative long time. In the first
study about the toxicity of PSB on mammalian breast epithelial cells (MCF10A), the cells were just immerged
in PBS for a short time length43. In this study, PSB was only used to affect the growth of cancer cells for several
hours before we used the untreated DMEM to replace PSB and further sustain the culture overnight. Finding
a proper culture time for the cancer cells in PSB is necessary for an effective comparison with PSM. In plasma,
the common way to use PSM is just culturing cells in PSM overnight or for several days (Fig. 1). Thus, we first
investigated whether the initial several hours of culture were important for the toxicity of PSM on PA-TU-8988T
cells. Specifically, PA-TU-8988T cells grown on a 96-wells plate were cultured for 24 hours. Following the protocols in methods about making PSM, 1 mL of PSM were made by a 3 min of CAP treatment on DMEM. 100 μL of
PSM was transferred to affect the growth of PA-TU-8988T cells immediately. Afterward, 100 μL of new DMEM
replaced PSM to culture cancer cells and changed every hour after the treatment until the fourth hour (Fig. 2a).
Finally, PA-TU-8988T cells were cultured for 24 hours followed by the cell viability assay according the protocols
in Methods. For MDA-MB-231 cells, the protocols were similar except the CAP treatment was performed on
6-wells plate for 1 min with the same changing of media as above.
It is found that removing the PSM which has been cultured with the cancer cells for 2 to 4 hr could not change
the toxicity of PSM on MDA-MB-231 cells and PA-TU-8988T cell viability (Fig. 2a and b). The noticeably weakened anti-cancer capacity only occurred when PSM was removed prior to 1 hr after the initiation of treatment
(Fig. 2a and b). To further confirm this trend, we investigated the anti-cancer capacity of PSM on PA-TU-8988T
cells by replacing PSM with new DMEM 3 hr after using PSM to affect cells. PSM was made by treating 1 mL of
DMEM in a 12-wells plate with CAP. Compared with the case that just culturing PA-TU-8988T cells in PSM for
1 day, removing PSM from the culturing environment of PA-TU-8988T cells just 3 hr after the treatment, did not
produce noticeable difference in terms of anti-cancer capacity (Fig. 2c).
These observations indicate that the anti-cancer reactive species in PSM has been significantly consumed in
the initial several hours after the CAP treatment. Thus, we further investigated the residual H2O2 concentration
in PSM and PSB which was used to culture cancer cells for several hours. The protocols are illustrated in Methods.
We identified a significant consumption of H2O2 in PSM by the two cancer cell lines in the initial 3 hr (Fig. 2d).
U87MG cells consumed H2O2 faster than PA-TU-8988T cells did. In addition, the two cancer cell lines consumed
H2O2 at slightly faster rate in DMEM than that in PBS (Fig. 2d). The H2O2 in PSM has been completely consumed
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x
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Figure 2. The initial several hours after the treatment are key for the anti-cancer effect of PSS. After the
treatment for 2 to 4 hr, removing the PSM from cancer cells’ environment would not affect the anti-cancer effect
on PA-TU-8988T cells (a) and MDA-MB-231 cells (b). No change means that PSM were used to culture cancer
cells for 1 day without renewing the medium. (c) After the treatment for 3 hr, replacing the CAP-stimulated
(CAP’s) DMEM by the untreated DMEM just caused a similar anti-cancer effect on PA-TU-8988T cells as using
the CAP’s DMEM to affect cells did. (d) The extracellular H2O2 were completely consumed by cancer cells in
just 3 hr after the treatment. Results in (a), (b) and (c) are presented as the mean ± s.d. of two independently
repeated experiments performed in sextuplicate. Results in (d) are presented as the mean ± s.d. of two
independently repeated experiments performed in triplicate.

by U87MG cells just 2 hr after the treatment. The residual H2O2 in PSM and PSB have nearly been completely
consumed by two cell lines just in the initial 3 hr after the treatment. This result is consistent with the observation
that replacing PSM by new DMEM 3 hr after the treatment will not affect the anti-cancer capacity of PSM.
To compare the anti-cancer capacity of PSM and PSB, DMEM and PBS were treated by the CAP jet under the
same experimental conditions. The killing effect of PSM and PSB on cancer cells will be noticeable as long as the
treatment time was longer than 2 min. PSM was much more toxic to PA-TU-8988T cells than PSB when the CAP
treatment time was longer than 3 min (Fig. 3a). In contrast, PSB was much more toxic to U87MG cells than PSM
when the CAP treatment time was longer than 2 min (Fig. 3b). Pre-treating cancer cells with the intracellular
ROS scavengers such as D-mannitol48, rotenone50, apocynin50, as well as NAC13, 48, 51 can drastically counteract
the anti-cancer effect of CAP treatment. We further investigated the effect of NAC on the anti-cancer effect of
PSM and PSB. As shown in Fig. 3c and d, both 6 mM and 10 mM NAC could completely inhibit the killing effect
of PSM in the two cell lines. Particularly, for U87MG cells, 10 mM NAC resulted in a noticeably higher cell viability than 6 mM NAC does (Fig. 3d). On the contrary, the pre-treatment of NAC showed remarkably different
effects on the toxicity of PSB between two cell lines. For the PSB-treated U87MG cells, 6 mM NAC did not cause
a noticeable increase on the cell viability (Fig. 3d). However, 10 mM NAC significantly increased the cell viability
about 100% compared the cells treated by the PSB made by 5 min of CAP treatment. (Fig. 3d). For PA-TU-8988T
cells, both 6 mM and 10 mM NAC could not noticeably increase the viability of the PSB-treated cancer cells
(Fig. 3c). Based on these results, it appears that the two cell lines experience different cellular responses in PSM
and in PSB that lead to the decrease of tumor cell viability with different levels.
The CAP-originated reactive species including ROS and RNS have been regarded as the main anti-cancer
factors during the CAP treatment in vitro5. Despite many researchers regard H2O2 as the main anti-cancer species
generated by the CAP treatment18, 20–22, 24, 26, 34, 52–54, it is still disputable that RNS might be a key anti-cancer species55. We analyzed the role of NO2−, a widely confirmed CAP-originated RNS product53, 56, 57 in the anti-cancer
capacity of PSM. The NO2−concentration in PSM made by 1 min of CAP treatment was approximately 10 μM.
The toxicity on cancer cells of concentrations ranging from 100 μM to 900 μM NO2−-DMEM on PA-TU-8988T
cells, U87MG cells, as well as MDA-MB-231 cells were studied. Clearly, even 900 μM NO2−-DMEM which was
equivalent to a PSM experienced about 90 min of CAP treatment would not noticeably inhibit the growth of all
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x
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Figure 3. The different toxicities of PSM/PSB on cancer cells. (a) PA-TU-8988T cells. (b) U87MG cells. (c) Pretreating PA-TU-8988T cells with NAC. (d) Pre-treating U87MG cells. As we illustrated in Methods, PSB was
just used to culture cells for 3 hr before using new DMEM to replace it. Results are presented as the mean ± s.d.
of two independently repeated experiments performed in sextuplicate. Student’s t-test was performed and the
significance is indicated as ***p < 0.005, **p < 0.01, and *p < 0.05.
three cell lines at all (Figs 4 and S1). Thus, NO2− at least does not independently contribute to the toxicity of PSM
to cancer cells.
The toxicity of H2O2-DMEM and H2O2-PBS on PA-TU-8988T cells and U87MG cells were also investigated.
We identified that 1 min of CAP treatment in DMEM or PBS would generate 36.3 μM H2O2. Thus, 36.3 μM
H2O2-DMEM/PBS was the 1 min- equivalent CAP-stimulated DMEM/PBS. As shown in Fig. 5, the vulnerability
of the two cell lines to H2O2 was also cell-dependent. For PA-TU-8988T cells, when the H2O2 concentration was
larger than 36.3 μM, H2O2-DMEM has significantly higher toxicity to cancer cells than H2O2-PBS. On the contrary, when the H2O2 concentration was larger than 72.6 μM, H2O2-PBS there was significantly more toxicity to
for U87MG cells than H2O2-DMEM. Such cell-dependent difference is well consistent with the trends obtained
from experiments based on PSS (Fig. 3), which again confirms that H2O2 is the main anti-cancer species in PSS
compared with NO2−.
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x

6

www.nature.com/scientificreports/

Figure 4. The toxicity of NO2− on cancer cells. (a) PA-TU-8988T cells. (b) U87MG cells. Results are presented
as the mean ± s.d. of three independently repeated experiments performed in sextuplicate.

Figure 5. The toxicity of the H2O2-DMEM and the H2O2-PBS on cancer cells. (a) PA-TU-8988T cells. (b)
U87MG cells. As we illustrated in Methods, H2O2-PBS was just used to culture cells for 3 hr before using new
DMEM to replace it. 36.8 μM of H2O2-PBS/DMEM is the equivalent solution of 1 min of CAP-stimulated PBS/
DMEM. Results are presented as the mean ± s.d. of three independently repeated experiments performed in
sextuplicate.

The rise of intracellular ROS is regarded as a key cellular response to the CAP treatment5, 58. The disturbed redox
balance31, 54, serious DNA damage13, 59, 60, as well as mitochondria damage15, 48, 61 may be all caused by the rise of
intracellular ROS. H2DCFDA is a common intracellular ROS probe used in plasma medicine13, 17, 48, 51, 52, 56. In this
study, we also used H2DCFDA as the probe. Following the protocols provided by the manufacturer, the intracellular ROS measurement needs a high cell confluence (25 × 104 cells/mL). Because the cellular response to the CAP
treatment is highly confluence-dependent21, 24, such high confluence needs a very high reactive species concentration to generate an observable cellular response. Thus, 10 min-equivalent (367.5 μM) and 20 min-equivalent
(735 μM) H2O2-rich DMEM/PBS were used to simulate the response of cancer cells to the PSS with a similar
H2O2 concentration. For PA-TU-8988T cells, H2O2-DMEM caused a stronger intracellular ROS rise than that
seen in H2O2-PBS (Fig. 6a). For U87MG cells, H2O2-PBS caused a stronger intracellular ROS rise than that seen
in H2O2-DMEM (Fig. 6b). The trends observed in the rise of intracellular ROS explain the trends observed in the
anti-cancer capacity of PSS (Figs 3a and b). The noticeable rise of intracellular ROS in the PSM-treated cancer
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x
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Figure 6. The different intracellular ROS changes due to the H2O2 treatment. (a) PA-TU-8988T cells. (b)
U87MG cells. Results are presented as the mean ± s.d. of two independently repeated experiments in triplicate.
Student’s t-test was performed and the significance is indicated as ***p < 0.005, **p < 0.01, and *p < 0.05.

cells rather than in the PSB-treated cancer cells has also been observed recently30. Based on all above results, it is
reasonable to conclude that the different toxicities of PSS on different cancer cell lines is at least partially due to
the different rise of intracellular ROS in different cancer cells exposed to the reactive species particularly H2O2
in PSS. An optimized strategy for using PSM and PSB in cancer treatment should therefore be cell-dependent.
In fact, DMEM a solution with abundant nutrient and PBS a solution with few nutrients should be regarded
as the extreme cases in biologically adaptable solutions. We further identified a general trend for other biological
adaptable solutions through investigating the dilution effect of PBS in DMEM on the anti-cancer effect of PSS.
Following the protocols in Methods, a series of diluted DMEM solutions were made by increasing the volume
fraction of PBS in DMEM from 0% (v/v) to be 90% (v/v). The volume fraction is also named as the dilution
fraction or the dilutability in this study. The dilution effect on the killing effect of PSM over MDA-MB-231 cells,
PA-TU-8988T cells, as well as U87MG cells were studied. Despite the dilution on DMEM did not change the
H2O2 concentration in PSS (Fig. 7a), the dilution effect showed a remarkable impact on the anti-cancer capacity
of PSS. For MDA-MB-231 cells and PA-TU-8988T cells, the effect of cancel cell viability drastically decreased as
the dilutability in DMEM increased when the treatment time was 1 min (Fig. 7b and c). In other words, the dilution in DMEM protected these cell lines from the attack of reactive species. When the treatment time increases
to 2 min, a noticeable increased anti-cancer effect is obtained in all experiments with different dilution levels. The
trend that the CAP-stimulated highly diluted DMEM is more resistant to the effect of reactive species still exists
(Fig. 7b and c). These results indicate that the dilution effect may change the threshold of cancer cells to the effect
of the CAP-originated species, rather than a difference in the actual CAP-originated species generated (Fig. 7a).
For U87MG cells, the dilution effect exerts a similar but a weaker dilution effect even up to a CAP treatment
time of 3 min (Fig. 7d). Such a difference may be due to the much stronger resistance seen in U87MG cells to the
CAP treatment compared with PA-TU-8988T cells and MDA-MB-231 cells21, 24. However, when the dilutability
increases from 80% to 90%, the killing effect of PPS on U87MG cells is decreased. In short, the dilution effect as a
new factor can drastically regulate the anti-cancer capacity of PSS.

Discussion

The anti-cancer capacity of PSS mainly PSM has been demonstrated over the past 5 years. From these studies, the
reactive species H2O2, NO2−, as well as NO3− have been regarded as the main factors affecting the death of cancer
cells18, 20–22, 24, 26, 27, 34, 37. On the contrary, the biologically adaptable buffered solution such DMEM and PBS have
just been regarded as a carrier for the dissolved CAP-originated reactive species16–28, 34–37. Such understanding
can satisfactorily explain the common observation that PSM, the most commonly investigated PSS, is an effective
anti-cancer tools on several cell lines in vitro. This explanation conflicts with the observation that directly using
PSB to affect cells will just generate a much weaker and perhaps a negligible killing effect compared with using
PSM30, 43.
In this study, through a comprehensive investigation on the anti-cancer effect of PSM and PSB on pancreatic
adenocarcinoma cells and glioblastoma cells, and the rise of intracellular ROS in these cells upon the treatment
of PSM and a PSB, we can give a comprehensive explanation to previous conflicting observations. First, the concentration of the main toxic reactive species H2O2 in PSM and PSB is the same (Fig. 6a). Second, both PSM and
PSB are toxic to cancer cells as long as the CAP treatment time is adequately long, such as 4–5 min revealed in
this study (Fig. 3a and b). Particularly for the experiment using H2O2-DMEM or H2O2-PBS, their strong toxicities
on pancreatic adenocarcinoma cells and glioblastoma cells clearly demonstrate the reactive species such as H2O2
can kill cancer cells culture in DMEM or PBS (Fig. 5a and b). Thus, the earliest observation that the mammalian
cells immersed in PBS did not experience DNA damage upon the CAP treatment may be partially due to a relatively weak CAP treatment dose43. Based on this study, it is reasonable to speculate that serious DNA damage and
apoptosis in cancer cells will also occur as long as the CAP treatment is adequately long even if just PSB has been
used to affect cancer cells.
More importantly, the anti-cancer effect of PSM/PSB is cell-dependent (Fig. 3a and b). Specifically, PSM
is much more toxic than PSB on PA-TU-8988T cells. On the contrary, PSB is much more toxic than PSM on
U87MG cells. And, this trend will not be changed if these cells are just treated by H2O2-DMEM and H2O2-PBS
(Fig. 5a and b). Thus, such specific cellular response of cancer cells to PSM or PSB is at least partially determined
Scientific Reports | 7: 4479 | DOI:10.1038/s41598-017-04770-x
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Figure 7. The dilution in medium by PBS significantly weakens the anti-cancer capacity of PSS in some cancer
cell lines. (a) The concentration of H2O2 in the PSM with different dilutabilities. (b) Breast adenocarcinoma
cell line (MDA-MB-231). (c) Pancreas adenocarcinoma cell line (PA-TU-8988T). (d) Glioblastoma cell
line (U87MG). 0% of dilutability and 90% of dilutability represents a mixed DMEM composed of 0% (v/v)
PBS + 100% (v/v) DMEM and a mixed DMEM composed of 90% (v/v) PBS + 10% (v/v) DMEM, respectively.
Result in (a) presented as the mean ± s.d. of three independently repeated experiments performed in triplicate.
Results in (b,c and d) presented as the mean ± s.d. of three independently repeated experiments performed in
sextuplicate.

by the specific cellular response of cancer cells in H2O2-containing environment. In addition, we identified that
the rise of intracellular ROS upon the treatment of H2O2-DMEM and H2O2-PBS is also cell-dependent (Fig. 6a
and b). Thus, the stronger rise of intracellular ROS in one cancer cell line than another cell line is also determined
by the specific response of cancer cells to reactive species such as H2O2 in a specific extracellular environment
such as DMEM or PBS. Based on our findings, it is reasonable to speculate that the previous conflicting observations about the stronger anti-cancer effect of PSM compared with PSB may just reflect one component of the
whole picture revealed in this study.
Understanding the different intracellular ROS levels in pancreatic adenocarcinoma cells and glioblastoma
cells affected by PSM and PSB may be the key to explain the distinct responses of cancer cells to PSM and PSB.
We propose that different cellular responses in the nutrient-rich and the nutrient-starved environment may cause
cancer cells to show different responses to the extracellular reactive species such as H2O2 (Fig. 8). When cells are
cultured in a nutrient-rich environment such as in DMEM, most reactive species such as H2O2 may diffusion into
the cytosol of cancer cells. The damage on the cellular membrane may be a minor factor to cause the cell death.
Recently, we have demonstrated that the diffusion process is controlled by aquaporins; an important membrane
channel for H2O262. Knocking out one specific aquaporin, AQP8, significantly weakens the anti-cancer capacity of
PSM on U87MG cells62. When cells are in PBS, the nutrient starvation may force cancer cells to enter an unusual
state. For PA-TU-8988T cells, the nutrient starvation may inhibit the transmembrane diffusion of reactive species and inhibit the rise of intracellular ROS via an unknown mechanism. As a result, the damage on the cellular
membrane may be stronger than that occurs in a nutrient-rich environment such as in DMEM. For U87MG cells,
the nutrient starvation may enhance the transmembrane diffusion of reactive species and the rise of intracellular ROS also via an unknown mechanism. And, based on this model, it is possible to explain the observation in
Fig. 3c and d that pre-treating cells with NAC can just counterpart the killing effect of PSB on U87MG cells rather
than on PA-TU-8988T cells. Pre-treating cancer cells with NAC can just scavenge the intracellular ROS, rather
than the extracellular ROS. In addition, the rise of intracellular ROS may also be due to other intracellular mechanisms, such as the generation of mitochondrial ROS in the early programmed cell death63. Further research on
this mechanism governing the cell-dependent rise of ROS and other cellular damages such as membrane damage
due to PSS is needed.
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Figure 8. A schematic diagram to illustrate the proposed mechanism governing the different cellular responses
in the CAP-stimulated DMEM and PBS. The intracellular ROS-based cell death pathways and other death
pathways such as the cellular membrane damage-based cell death may coexist after the indirect CAP treatment.

In our previous studies, several important factors which will affect the anti-cancer capacity of PSM have been
proposed21. These factors include the contact area between CAP and the solution, the volume of the solution, as
well as the distance between the CAP source and the solution21. A reasonable controlling these factors will obtain
a stronger PSM without increasing the treatment time and dose. This study demonstrates a novel important factor, the dilutability of PSS. For some cell lines such as PA-TU-8988T and MDA-MB-231, the decrease of the nutrient components in DMEM will significantly weaken the anti-cancer capacity of PSM. For U87MG cells, a much
weaker but similar trend has also observed as long as the dilution fraction is not too large; i.e. 90%. The impact of
the dilution effect may be partially due to that fact that the cancer cells’ response to PSS is specifically determined
by both the type of cancer cell and the components of solutions used to make PSS. In short, the biologically adaptable solutions such as PBS, DMEM, as well as the diluted DMEM are not just the carriers for the CAP-originated
reactive species but also actively affect the killing process of PSS on cancer cells.

Conclusions

In summary, the anti-cancer capacity of the cold plasma-stimulated solutions is both cell-dependent and
dilutability-dependent. Pancreatic cancer cells and glioblastoma cells are highly vulnerable to the cold
plasma-stimulated DMEM and the cold plasma-stimulated PBS, respectively. Such cell-dependent response may
be due to the differential rise of intracellular reactive oxygen species of cancer cells in the specific H2O2-containing
environment. However, the cold plasma-stimulated solutions alone can be a strong anti-cancer tool as long as the
CAP treatment is of adequate duration long. Moreover, the dilutability of the solution is a very important factor
affecting the anti-cancer capacity of the cold plasma-stimulated solution. For pancreatic cancer cells and breast
cancer cells, the dilution on medium will significantly weaken the toxicity of the cold plasma-stimulated medium
over these cells. For glioblastoma cells, the dilution will not noticeably affect the anti-cancer capacity of the cold
plasma-stimulated medium.
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